drugset / Trial / NCT00338338
The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The sustained reduction in elevated blood pressure and lower incidence of adverse events of Lacidipine may provide additional benefits for hypertension patients than other CCBs (calcium channel blockers). This study is to compare the efficacy and safety of Lacidipine with Amlodipine, the most widely used CCB in Taiwan, in hypertensive patients.
Timeline
- Start
- 2005-11-07
- Primary completion
- 2007-09-14
- Completion
- 2007-09-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |
| Subject | Lacidipine | Small molecule | 4 mg | Oral |
| Subject | Lacidipine | Small molecule | 6 mg | Oral |